» Authors » Fabiana Morroni

Fabiana Morroni

Explore the profile of Fabiana Morroni including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 39
Citations 826
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Graziosi A, Corrieri C, Sita G, Ghelli L, Angelini S, dEmmanuele di Villa Bianca R, et al.
Sci Rep . 2025 Jan; 15(1):2722. PMID: 39837947
Environmental endocrine disruptor chemicals (EDCs) have raised significant concerns due to their potential adverse effects on human health, particularly on the central nervous system (CNS). This study provides a comparative...
2.
Morroni F, Caccamo A
J Alzheimers Dis . 2024 Oct; 101(s1):S417-S431. PMID: 39422937
Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by cognitive decline, memory loss, and behavioral impairments. Despite extensive research efforts, effective treatment options for AD remain limited. Recently, gene...
3.
Esposito E, Indolfi C, Bello I, Smimmo M, Vellecco V, Schettino A, et al.
Eur J Pharmacol . 2024 Jun; 977:176758. PMID: 38901528
Vinclozolin (VCZ) is a common dicarboximide fungicide used to protect crops from diseases. It is also an endocrine disruptor, and its effects on various organs have been described but its...
4.
Di Vito A, Mandrone M, Chiocchio I, Gorini F, Ravegnini G, Coschina E, et al.
Plants (Basel) . 2024 May; 13(9). PMID: 38732416
Novel treatments in gastrointestinal stromal tumors (GISTs) are essential due to imatinib resistance and the modest results obtained with multi-target tyrosine kinase inhibitors. We investigated the possibility that the hydroalcoholic...
5.
Sita G, Graziosi A, Corrieri C, Ghelli L, Angelini S, Cortelli P, et al.
Int J Mol Sci . 2023 Nov; 24(22). PMID: 38003389
Alzheimer's disease (AD) represents the most frequent type of dementia worldwide, and aging is the most important risk factor for the sporadic form of the pathology. The endoplasmic reticulum (ER),...
6.
Di Vito A, Ravegnini G, Gorini F, Aasen T, Serrano C, Benuzzi E, et al.
Pharmacol Ther . 2023 Jun; 248:108475. PMID: 37302758
Gastrointestinal stromal tumors (GISTs) are rare mesenchymal sarcomas and the gold-standard treatment is represented by tyrosine kinase inhibitors (TKIs). Unfortunately, first-line treatment with the TKI imatinib usually promotes partial response...
7.
Dothel G, Barbaro M, Di Vito A, Ravegnini G, Gorini F, Monesmith S, et al.
J Gastroenterol . 2023 May; 58(7):605-621. PMID: 37160449
Irritable bowel syndrome (IBS) is a complex multifactorial condition including alterations of the gut-brain axis, intestinal permeability, mucosal neuro-immune interactions, and microbiota imbalance. Recent advances proposed epigenetic factors as possible...
8.
Graziosi A, Sita G, Corrieri C, Angelini S, dEmmanuele di Villa Bianca R, Mitidieri E, et al.
Int J Mol Sci . 2022 Dec; 23(23). PMID: 36498866
Endocrine-disrupting chemicals (EDCs) are different natural and synthetic chemicals that may interfere with several mechanisms of the endocrine system producing adverse developmental, metabolic, reproductive, and neurological effects in both human...
9.
Ravegnini G, Nannini M, Indio V, Serrano C, Gorini F, Astolfi A, et al.
Int J Mol Sci . 2022 Oct; 23(20). PMID: 36293105
Gastrointestinal stromal tumors (GISTs) harboring mutations in the gene occur in only about 5-7% of patients. The most common mutation is exon 18 D842V, which is correlated with specific clinico-pathological...
10.
Galbiati V, Buoso E, dEmmanuele di Villa Bianca R, Di Paola R, Morroni F, Nocentini G, et al.
Front Toxicol . 2022 Mar; 3:649024. PMID: 35295136
Endocrine disruptors (ED) are natural and anthropogenic chemicals that can interfere with hormonal systems at different levels. As such, ED-induced alterations in hormone functions have been implicated in many diseases...